Amkor Q2 net sales rise to $1.51 billion; EPS $0.22 vs $0.27 a year earlier
Amkor reported second quarter 2025 net sales of $1.51 billion, up from $1.32 billion in the first quarter and $1.46 billion a year earlier, while diluted EPS was $0.22 compared with $0.27 in the second quarter of 2024. Results include a $32 million net benefit to operating income from a contingency payment tied to its 2017 Nanium acquisition. The company guided third quarter 2025 net sales to $1.875 billion to $1.975 billion and diluted EPS to $0.34 to $0.48.
Key points
- Q2 2025 net sales were $1.51 billion, up 14% from $1.32 billion in Q1 2025 and above the high end of company guidance.
- Net income attributable to Amkor was $54 million, or $0.22 per diluted share, versus $67 million, or $0.27, in Q2 2024.
- A $32 million net benefit to operating income and EBITDA came from a contingency payment related to the May 2017 Nanium acquisition, adding $0.07 to EPS.
- Q3 2025 guidance: net sales of $1.875 billion to $1.975 billion, net income of $85 million to $120 million, and EPS of $0.34 to $0.48.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:17 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 28, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.